RESEARCH TRIANGLE PARK, N.C. –– Metabolon, Inc., the global leader in metabolomics, announced today that it has closed a financing that raised $15 million from new investor Essex Woodlands, a leading healthcare growth equity firm. Metabolon will use the proceeds to...
San Diego, CA (June 14, 2016)—Suneva Medical, Inc., a privately-held and innovative aesthetics leader, today announced the closing of a $25 million investment by Essex Woodlands. This financing strengthens Suneva Medical’s rapid revenue growth and further supports the...
HEMEL HEMPSTEAD, United Kingdom – – EUSA Pharma (EUSA), a recently-established profitable specialty pharmaceutical company with global reach, today announced the appointment of Lee Morley as Chief Executive Officer, and Dr Göran Ando as a Non-Executive Director. Bryan...
HEMEL HEMPSTEAD, United Kingdom—After completing a $700 million deal to sell EUSA Pharma Inc. to Jazz Pharmaceuticals PLC in 2012, Essex Woodlands has teamed up with EUSA’s founding Chief Executive Bryan Morton to spin the company back out again. Essex Woodlands was...
HEMEL HEMPSTEAD, United Kingdom –– EUSA Pharma (EUSA), a newly-established profitable specialty pharmaceutical business with global reach, today announced its official launch following the acquisition of five approved specialty hospital products, a multi-national...
LANGHORNE, Pennsylvania and OXFORD, United Kingdom -– EUSA Pharma, a transatlantic specialty pharmaceutical company focused on oncology, oncology supportive care and critical care, today announced that it has submitted a Biologics License Application (BLA) to the U.S....
